Amarantus Bioscience Holdings Total Liabilities 2010-2016 | AMBS

Amarantus Bioscience Holdings total liabilities from 2010 to 2016. Total liabilities can be defined as the total value of all possible claims against the corporation.

Amarantus Bioscience Holdings Total Liabilities 2010-2016 | AMBS

Amarantus Bioscience Holdings total liabilities from 2010 to 2016. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company NameMarket
Cap
Danaher (DHR)$149.7B
CVS Health (CVS)$89B
Elevance Health (ELV)$69.7B
Cencora (COR)$56.3B
DiDi Global (DIDIY)$27B
Labcorp Holdings (LH)$22.5B
Natera (NTRA)$22.1B
BioMerieux (BMXMF)$18B
EUROFINS SCIENT (ERFSF)$15.1B
ICON (ICLR)$14.4B
Medpace Holdings (MEDP)$13B
CochLear (CHEOY)$12.6B
Viatris (VTRS)$12.4B
Solventum (SOLV)$12.3B
Revvity (RVTY)$10.4B
Caris Life Sciences,�Inc (CAI)$10.1B
Sonic Healthcare (SKHHY)$9.2B
Avantor (AVTR)$8.7B
HealthEquity (HQY)$7.7B
Charles River Laboratories (CRL)$7.7B
Bausch + Lomb (BLCO)$5.1B
Sotera Health (SHC)$4.5B
BrightSpring Health Services (BTSG)$4.1B
Amplifon S.p.A (AMFPF)$3.9B
GeneDx Holdings (WGS)$3.6B
Alignment Healthcare (ALHC)$3B
Concentras Parent (CON)$2.9B
Surgery Partners (SGRY)$2.9B
Organon (OGN)$2.4B
Progyny (PGNY)$2B